Effect of lisinopril on progression of retinopathy in normotensive people with type 1 diabetes
Nish Chaturvedi(Imperial College London), John Fuller(The Royal Free Hospital), Heidemarie Abrahamian, Željka Rogulja-Pepeonik, Anne-Katrin Sjolie(Aarhus University Hospital), Allesandro Castellarin(University of Verona), Judith Stephenson(University College London), M Keipes
Cited by 743
Related Papers
Primary prevention of cardiovascular disease with atorvastatin in type 2 diabetes in the Collaborative Atorvastatin Diabetes Study (CARDS): multicentre randomised placebo-controlled trial
|The Lancet|2004|3.8k
Vascular Risk Factors and Diabetic Neuropathy
|New England Journal of Medicine|2005|1.3k
Effect of candesartan on prevention (DIRECT-Prevent 1) and progression (DIRECT-Protect 1) of retinopathy in type 1 diabetes: randomised, placebo-controlled trials
|The Lancet|2008|450